However, continuing to track how employers and payers are navigating the complex environment around these drugs is key to ensuring they can reach the right patients
According to FDA prescribing information for Wegovy (semaglutide 2.4 mg), nausea occurs in approximately 44% of patients taking the medication for weight loss, while vomiting affects roughly 24% of users at the maintenance dose
& Atkin, S
But along with slimmer waistlines, clinicians are seeing something else: faces that are thinning, sagging, and hollowing as if the patient has undergone decades of agingexcept its happening in months
Are GLP-1 medications approved for treating alcohol use disorder
Our platform can help you answer pressing questions about utilization, adherence, outcomes and more, empowering you to deliver better care and make smarter decisions